Research map: STAT3 inhibition eradicates multiple myeloma stem-like cells and induces immunogenic cell death

Back to the article

Papers in this map

  1. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 · Lorenzo Galluzzi · 2018 · 6767 citations · Cited by this paper
  2. STAT3 inhibition for the induction of immunogenic cell death in multiple myeloma · Oliver Kepp · 2026 · Cites this paper
  3. ITP, easy as EBV: a rare case of severe immune thrombocytopenic purpura secondary to Epstein-Barr virus · 2026 · Related
  4. Immunogenic cell death and DAMPs in cancer therapy · Dmitri V. Krysko · 2012 · 3239 citations · Cited by this paper
  5. CD7 CAR-T therapy: current developments, improvements, and dilemmas · 2025 · Related
  6. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death · Lorenzo Galluzzi · 2020 · 1119 citations · Cited by this paper
  7. Novel NUP98:TNRC18 fusion transcript in acute myeloid leukemia: a case report and literature review · 2025 · Related
  8. Targeting immunogenic cell death in cancer · Asma Sirageldin Ahmed · 2020 · 940 citations · Cited by this paper
  9. Single-cell transcriptomic dissection of two waves of endothelial-hematopoietic transition in a murine yolk sac · 2025 · Related
  10. Stem cell programs in cancer initiation, progression, and therapy resistance · Tianzhi Huang · 2020 · 568 citations · Cited by this paper
  11. Diagnostic value of mNGS for CNSIs in hematopoietic stem cell transplant patients · 2025 · Related
  12. Targeting immunogenic cell stress and death for cancer therapy · Lorenzo Galluzzi · 2024 · 532 citations · Cited by this paper
  13. A promising leap in treating large granular lymphocytic leukemia: reflections on a Multicenter Phase II Study of thalidomide-based therapy · 2025 · Related
  14. Suppression of cancer relapse and metastasis by inhibiting cancer stemness · Youzhi Li · 2015 · 465 citations · Cited by this paper
  15. The tumor microenvironment in hematologic malignancies: immune evasion, metabolic reprogramming, and therapeutic resistance · 2026 · Related
  16. Cancer stem cells, cancer cell plasticity and radiation therapy · Erina Vlashi · 2014 · 343 citations · Cited by this paper
  17. Application value and challenges associated with plasma cell-free DNA metagenomic sequencing technology in the diagnosis of infections in patients with hematological disorders · 2026 · Related
  18. Immunogenic Cell Death and Immunotherapy of Multiple Myeloma · Alfonso Serrano del Valle · 2019 · 204 citations · Cited by this paper
  19. Development and validation of nomograms for survival prediction in Fanconi anemia · 2025 · Related
  20. Oleandrin, a cardiac glycoside, induces immunogenic cell death via the PERK/elF2α/ATF4/CHOP pathway in breast cancer · Xiaoxi Li · 2021 · 164 citations · Cited by this paper
  21. The groundbreaking discovery of peripheral immune tolerance: identifying Treg cells and the FOXP3 gene, and their therapeutic potential · 2025 · Related
  22. Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor · Joleen Marie Hubbard · 2017 · 159 citations · Cited by this paper
  23. Targeted inhibition of STAT3 induces immunogenic cell death of hepatocellular carcinoma cells via glycolysis · Ya Li · 2022 · 98 citations · Cited by this paper
  24. Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker · Anastasios I. Birmpilis · 2022 · 94 citations · Cited by this paper
  25. STAT3: A Promising Therapeutic Target in Multiple Myeloma · Phyllis S.Y. Chong · 2019 · 93 citations · Cited by this paper
  26. Immunogenic Cell Death in Hematological Malignancy Therapy · Zhaoyun Liu · 2023 · 62 citations · Cited by this paper
  27. Albendazole inhibits NF-κB signaling pathway to overcome tumor stemness and bortezomib resistance in multiple myeloma · Hui Yi · 2021 · 45 citations · Cited by this paper
  28. Metabolic Disorders in Multiple Myeloma · Maria Gavriatopoulou · 2021 · 39 citations · Cited by this paper
  29. Hypoxia‐induced oxidative stress promotes therapy resistance via upregulation of heme oxygenase‐1 in multiple myeloma · Ko Abe · 2023 · 29 citations · Cited by this paper
  30. A redox-responsive nanosystem to suppress chemoresistant lung cancer through targeting STAT3 · Qiyi Feng · 2023 · 28 citations · Cited by this paper
  31. Apoptotic tumor cell-derived microparticles loading Napabucasin inhibit CSCs and synergistic immune therapy · Boping Jing · 2023 · 25 citations · Cited by this paper
  32. Identification and Characterization of Multiple Myeloma Stem Cell-Like Cells · Wancheng Guo · 2021 · 23 citations · Cited by this paper
  33. Lycorine targets multiple myeloma stem cell‐like cells by inhibition of Wnt/β‐catenin pathway · Haiqin Wang · 2020 · 22 citations · Cited by this paper
  34. Bortezomib Induces Immunogenic Cell Death in Multiple Myeloma · Laurence Zitvogel · 2021 · 22 citations · Cited by this paper
  35. Genetic and epigenetic mechanisms of GPRC5D loss after anti-GPRC5D CAR T-cell therapy in multiple myeloma · Sha Ma · 2025 · 22 citations · Cited by this paper
  36. The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics · Marlena Beyreis · 2019 · 20 citations · Cited by this paper
  37. Biological Hallmarks and Emerging Strategies to Target STAT3 Signaling in Multiple Myeloma · Jianbiao Zhou · 2022 · 20 citations · Cited by this paper
  38. Targeting cancer stem cells in multiple myeloma · Emine Gulsen Gunes · 2024 · 20 citations · Cited by this paper
  39. Novel mechanism of napabucasin, a naturally derived furanonaphthoquinone: apoptosis and autophagy induction in lung cancer cells through direct targeting on Akt/mTOR proteins · Korrakod Petsri · 2022 · 19 citations · Cited by this paper

Source: OpenAlex (CC0)